Metraipolis › archive › dc_a44d38d7cf32
SOCS1 Mimetic Peptide Enhances Empagliflozin Improvement on Kidney Damage in the Type 2 Diabetes Mouse Model BTBR ob/ob — Europe PMC PMID:41828692
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41828692
- DOI
- 10.3390/ijms27052466
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T00:38:46.910Z
- SHA-256 of the archived text
6fb97f8921b9b88d99c16c41550e5b22e4447b927334f78febd54c8f05d9f647- Stable URL of this page
https://metraipolis.com/documento/dc_a44d38d7cf32
How to cite
SOCS1 Mimetic Peptide Enhances Empagliflozin Improvement on Kidney Damage in the Type 2 Diabetes Mouse Model BTBR ob/ob — Europe PMC PMID:41828692 — Europe PMC (en), https://europepmc.org/article/MED/41828692 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a44d38d7cf32 (Metraipolis archive dc_a44d38d7cf32, sha256 6fb97f8921b9b88d99c16c41550e5b22e4447b927334f78febd54c8f05d9f647)
BibTeX
@misc{dca44d38d7cf32,
title = {SOCS1 Mimetic Peptide Enhances Empagliflozin Improvement on Kidney Damage in the Type 2 Diabetes Mouse Model BTBR ob/ob — Europe PMC PMID:41828692},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41828692},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a44d38d7cf32; sha256 6fb97f8921b9b88d99c16c41550e5b22e4447b927334f78febd54c8f05d9f647},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41828692. Agents can read the archived copy with the MCP tool read_document.